Dll3/Cd3 Binding Proteins For The Treatment Of Cancer - EP4566621
The patent EP4566621 was granted to Boehringer Ingelheim on Aug 20, 2025. The application was originally filed on Jun 7, 2019. The patent is currently recorded with a legal status of "Pending".
EP4566621
- Filing Date
- Jun 7, 2019
- Status
- Pending
- Grant Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents